Oral Presentation at ASH 2025 Shows Canopy RTM Cuts Infection-Related Hospitalizations by 52% and Generates Nearly $1M in Annual Savings per 1,000 Patients
New data demonstrate the potential of Canopy's Remote Therapeutic Monitoring (RTM) Platform to improve patient care by reducing serious infections in patients with hematologic malignancies, resulting in an estimated $977,695 in annual savings per 1,000 patients. Canopy, the leader in Enterprise AI for oncology, today announced new findings that highlight how its RTM Platform strengthens outpatient care and reduces infection-related escalations in patients with hematological malignancies.
Read more







